Showing 2,101 - 2,120 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (greater decrease)) ))', query time: 1.65s Refine Results
  1. 2101
  2. 2102
  3. 2103
  4. 2104
  5. 2105
  6. 2106
  7. 2107
  8. 2108

    Table_1_Decreased Serum Brain-Derived Neurotrophic Factor Concentrations 72 Hours Following Marathon Running.DOCX by Astrid Roeh (11136600)

    Published 2021
    “…</p><p>Conclusion: Prolonged exercise induces a significant decrease in serum BDNF concentration 72 h post-exercise. …”
  9. 2109
  10. 2110
  11. 2111
  12. 2112
  13. 2113
  14. 2114
  15. 2115

    <i>Dmxl2</i> knockdown in INS-1E cells decreases glucose-induced insulin release. by Brooke Tata (633065)

    Published 2014
    “…<p>(A) Rbcn-3α is expressed in insulin-secreting cells in the islets of Langerhans in the mouse pancreas. …”
  16. 2116
  17. 2117
  18. 2118

    Data_Sheet_1_Melatonin Supplementation Decreases Hypertrophic Obesity and Inflammation Induced by High-Fat Diet in Mice.PDF by Talita da Silva Mendes de Farias (7818617)

    Published 2019
    “…The results demonstrate that melatonin supplementation attenuated serum triglyceride levels and total and LDL cholesterol and prevented body mass gain through a decreased lipogenesis rate and increased lipolytic capacity in white adipocytes, with a concomitant increment in oxygen consumption and Pgc1a and Prdm16 expression. …”
  19. 2119
  20. 2120

    Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment by Sigurdardottir G. (5710955)

    Published 2018
    “…<b><i>Methods:</i></b> The levels of 17 potential biomarkers with an association with cardiovascular risk were quantitated in plasma from 37 age- and gender-matched psoriasis patients and controls at baseline and in 21 psoriasis patients after 12 weeks of NB-UVB treatment to identify a systemic treatment response. <b><i>Results:</i></b> We identified the mediators endocan-1, CXCL16, and sVEGFR1, which were systemically decreased in psoriasis at baseline, as well as FABP3, FABP4, and sIL-1R1, which showed normal baseline levels. …”